{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:16:52Z","timestamp":1783703812790,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijpharm.2018.08.062","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T12:31:48Z","timestamp":1535805108000},"page":"359-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation"],"prefix":"10.1016","volume":"550","author":[{"given":"Mohammed","family":"Elmowafy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazim M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Abdel-Bakky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.ijpharm.2018.08.062_b0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.colsurfa.2007.07.035","article-title":"Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity","volume":"315","author":"Attama","year":"2008","journal-title":"Colloids Surf. A: Physicochem. Eng. Aspects"},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.062_b0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ejlt.200401105","article-title":"Physico\u2010chemical parameters for the characterization of pure beeswax and detection of adulterations","volume":"107","author":"Bernal","year":"2005","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0015","series-title":"Tumor Necrosis Factor and Lymphotoxin","first-page":"335","author":"Beyaert","year":"1998"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.apt.2012.09.002","article-title":"Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles","volume":"24","author":"Burra","year":"2013","journal-title":"Adv. Powder Technol."},{"issue":"s2","key":"10.1016\/j.ijpharm.2018.08.062_b0025","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2018.08.062_b0030","doi-asserted-by":"crossref","first-page":"(3)","DOI":"10.1208\/s12249-015-0391-0","article-title":"Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via nanostructured lipid carrier (NLC) formulation","volume":"17","author":"Elmowafy","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.08.062_b0035","article-title":"Fatty alcohol containing nanostructured lipid carrier (NLC) for progesterone oral delivery. In vitro and Ex vivo studies","volume":"45","author":"Elmowafy","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.11.064","article-title":"Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin","volume":"162","author":"Fathi","year":"2018","journal-title":"Colloids Surf., B"},{"issue":"9","key":"10.1016\/j.ijpharm.2018.08.062_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21937","article-title":"Ellagic acid and rosmarinic acid attenuate doxorubicin\u2010induced testicular injury in rats","volume":"31","author":"Georgy","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"9","key":"10.1016\/j.ijpharm.2018.08.062_b0055","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.3390\/ph3092884","article-title":"\u201cAntiepileptic drug discovery and development: what have we learned and where are we going?\u201d","volume":"3","author":"Gerlach","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.ijpharm.2018.08.062_b0060","first-page":"541","article-title":"Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment","volume":"18","author":"Gnessi","year":"1997","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.383","article-title":"In Vitro investigation on the impact of the surface\u2010active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam","volume":"25","author":"Gonz\u00e1lez","year":"2004","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0070","first-page":"CA2082137","article-title":"Aliphatic esters as a solventless coating for pharmaceuticals","author":"Gowan","year":"1993","journal-title":"Can. Pat. Appl."},{"issue":"11","key":"10.1016\/j.ijpharm.2018.08.062_b0075","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jps.10455","article-title":"Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I","volume":"92","author":"Grzesiak","year":"2003","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2015.11.015","article-title":"Polyethylene glycols in oral and parenteral formulations\u2014A critical review","volume":"496","author":"Gullapalli","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ijpharm.2018.08.062_b0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based formulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ijpharm.2018.08.062_b0090","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.187.6.917","article-title":"Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock","volume":"187","author":"Hierholzer","year":"1998","journal-title":"J. Exp. Med."},{"issue":"3\u20134","key":"10.1016\/j.ijpharm.2018.08.062_b0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf., B"},{"issue":"7","key":"10.1016\/j.ijpharm.2018.08.062_b0100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/dmd.115.063370","article-title":"Carbamazepine-induced liver injury requires CYP3A-mediated metabolism and glutathione depletion in rats","volume":"43","author":"Iida","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(99)00412-3","article-title":"Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide","volume":"196","author":"Jacobs","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jiec.2013.04.034","article-title":"Novel blend microspheres of cellulose triacetate and bee wax for the controlled release of nateglinide","volume":"20","author":"Kajjari","year":"2014","journal-title":"J. Ind. Eng. Chem."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.062_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03256188","article-title":"Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events","volume":"21","author":"Kalapos","year":"2002","journal-title":"Adverse Drug React. Toxicol. Rev."},{"issue":"9204","key":"10.1016\/j.ijpharm.2018.08.062_b0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(99)00219-6","article-title":"Serum aminotransferase concentration as evidence of hepatocellular damage","volume":"355","author":"Kew","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijpharm.2018.08.062_b0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.nano.2010.06.003","article-title":"Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax","volume":"6","author":"Kheradmandnia","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.062_b0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(90)90258-8","article-title":"Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis.","volume":"181","author":"K\u00fchn-Velten","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijpharm.2018.08.062_b0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.addr.2011.10.003","article-title":"Host factors affecting antiepileptic drug delivery\u2014pharmacokinetic variability","volume":"64","author":"Landmark","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.062_b0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1248\/bpb.19.394","article-title":"Behavioral studies on alkaloids extracted from the leaves of Hunteria Zeylanica","volume":"19","author":"Leewanich","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/17425247.2017.1395853","article-title":"Strategies and industrial perspectives to improve oral absorption of biological macromolecules","volume":"15","author":"Liu","year":"2018","journal-title":"Exp. Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0150","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1124\/jpet.106.104968","article-title":"The mechanism of carbamazepine aggravation of absence seizures","volume":"319","author":"Liu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"238","key":"10.1016\/j.ijpharm.2018.08.062_b0155","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1016\/j.toxlet.2015.08.1024","article-title":"Protein adducts from carbamazepine-10, 11-epoxide, the major metabolite of the antiepileptic drug carbamazepine: possible biomarkers of toxicity","volume":"2","author":"Martins","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfb.2018.03.052","article-title":"Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro\/in vivo evaluation","volume":"167","author":"Montoto","year":"2018","journal-title":"Colloids Surf., B"},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0897.1991.tb00972.x","article-title":"Peritoneal fluid lnterleukin\u20101\u03b2 and tumor necrosis factor in patients with benign gynecologic disease","volume":"26","author":"Mori","year":"1991","journal-title":"Amerian Journal of Reproductive Immunology"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.062_b0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(00)00586-X","article-title":"Potential Inhibitory effects of formulation ingredients on intestinal cytochrome P450","volume":"211","author":"Mountfield","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.08.062_b0180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1023\/A:1012043315093","article-title":"Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant","volume":"14","author":"M\u00fcller","year":"1997","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0185","first-page":"5","article-title":"\u201cHepatoprotective effect of the aqueous extract and 5-hydroxy, 7, 8, 2\u2032 trimethoxy flavone of andrographis alata nees. In carbon tetrachloride treated rats.","volume":"10","author":"Nagaraja","year":"2016","journal-title":"Achiev. Life Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1476-511X-11-72","article-title":"Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine","volume":"11","author":"Nair","year":"2012","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0939-6411(01)00173-4","article-title":"Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate","volume":"52","author":"Obaidat","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0200","series-title":"Martindale: The Complete Drug Reference","first-page":"854","author":"Parfit","year":"1999"},{"issue":"7","key":"10.1016\/j.ijpharm.2018.08.062_b0205","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ijpharm.2018.08.062_b0210","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1166\/jnn.2007.809","article-title":"\u201cSolid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems","volume":"7","author":"Priano","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"5)","key":"10.1016\/j.ijpharm.2018.08.062_b0215","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s10856-010-4034-4","article-title":"Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent","volume":"21","author":"Ranjha","year":"2010","journal-title":"J. Mater. Sci. \u2013 Mater. Med."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0731-7085(00)00262-4","article-title":"Solid-state study of polymorphic drugs: carbamazepine","volume":"23","author":"Rustichelli","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.eplepsyres.2013.08.011","article-title":"Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study","volume":"107","author":"Sankhyan","year":"2013","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/taap.2001.9304","article-title":"the role of tumor necrosis factor-\u03b1 in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride","volume":"177","author":"Simeonova","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.08.062_b0235","first-page":"110","article-title":"Effects of antiepileptic drugs carbamazepine and sodium valproate on fertility of male rats","volume":"106","author":"Soliman","year":"1999","journal-title":"Dtsch. Tierarztl. Wochenschr."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0240","unstructured":"Sukuru, Karunakar., 2012. Hydrophilic Vehicle-Based Dual Controlled Release Matrix System. Google Patent."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0245","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1208\/pt0801024","article-title":"Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles","volume":"8","author":"Suresh","year":"2007","journal-title":"Aaps Pharmscitech"},{"issue":"1\u20133","key":"10.1016\/j.ijpharm.2018.08.062_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfa.2010.09.030","article-title":"Surfactant effects on the physical characteristics of amphotericin b-containing nanostructured lipid carriers.","volume":"372","author":"Tan","year":"2010","journal-title":"Colloids Surf., A"},{"issue":"2","key":"10.1016\/j.ijpharm.2018.08.062_b0255","first-page":"120","article-title":"\u201cDisorders of reproduction in epilepsy\u2014what can we learn from animal studies?\u201d Seizure-European","volume":"17","author":"Taub\u00f8ll","year":"2008","journal-title":"J. Epilepsy"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.08.062_b0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2007.01.015","article-title":"Cetyl palmitate-based NLC for topical delivery of coenzyme Q10\u2013development, physicochemical characterization and in vitro release studies","volume":"67","author":"Teeranachaideekul","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.08.062_b0265","series-title":"Models of Seizures and Epilepsy","first-page":"127","article-title":"Models of chemically-induced acute seizures","author":"Velisek","year":"2006"},{"key":"10.1016\/j.ijpharm.2018.08.062_b0270","first-page":"S74","article-title":"Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy","volume":"32","author":"Wyllie","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2018.08.062_b0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.envpol.2017.04.007","article-title":"Molecular toxicity of triclosan and carbamazepine to green algae Chlorococcum Sp.: a single cell view using synchrotron-based fourier transform infrared spectromicroscopy","volume":"226","author":"Xin","year":"2017","journal-title":"Environ. Pollut."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.062_b0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2010.04.039","article-title":"The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.","volume":"394","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijpharm.2018.08.062_b0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejps.2009.05.001","article-title":"Effects of polyoxyethylene (40) stearate on the activity of p-glycoprotein and cytochrome P450","volume":"37","author":"Zhu","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.08.062_b0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","article-title":"Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability","volume":"394","author":"Zhuang","year":"2010","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:38:14Z","timestamp":1759916294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318306471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":58,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0378517318306471"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.062","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}